Jérôme Clerc - Concepedia

Author

Jérôme Clerc

Assistance Publique – Hôpitaux de Paris ORCID

Also Known As

Clerc, Jérôme, J Clerc, Jérôme Clerc, J. Clerc, J??R??ME CLERC, Jerome Clerc, Jerôme Clerc, Jérôme Clerc, JÉRÔME CLERC, Jérome Clerc

137

Publications

2.9K

Citations

H-Index

104

Concepts

All Affiliations

Assistance Publique – Hôpitaux de Paris Inserm Université Paris Cité Hôpital Cochin University of Duisburg-Essen

About

Jérôme Clerc is an author at Assistance Publique – Hôpitaux de Paris specializing in medicine, nuclear medicine, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	22	1.1K
2	Engineering	7	7	193
3	Health Sciences	7	7	278
4	Natural Sciences	4	4	220
5	Public Health	4	4	144

Jérôme Clerc

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET/CT† Anne‐Ségolène Cottereau, Michel Meignan, Christophe Nioche, Annals of Oncology Hematological MalignancyLymphoid NeoplasiaOncologic ImagingMedicinePathology	2020	190
<sup>18</sup>F-FDG PET Dissemination Features in Diffuse Large B-Cell Lymphoma Are Predictive of Outcome Anne‐Ségolène Cottereau, Christophe Nioche, Anne-Sophie Dirand, Journal of Nuclear Medicine	2019	164
Decreased uptake of therapeutic doses of iodine-131 after 185-MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma F. Léger, M Izembart, F Dagousset, European Journal of Nuclear Medicine and Molecular Imaging Health SciencesIodine Deficiency DisordersThyroid DiseaseRadiopharmaceutical TherapyTherapeutic Doses	1998	141
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial Johanne Silvain, Benoît Lattuca, Farzin Beygui, The Lancet Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseMedicineCardiovascular Pharmacology	2020	122
Polyendocrinopathy Resulting From Pembrolizumab in a Patient With a Malignant Melanoma A.C. Paepegaey, C. Lheure, Carole Ratour, Journal of the Endocrine Society	2017	100
Synthetic and structural studies on syringolin A and B reveal critical determinants of selectivity and potency of proteasome inhibition Jérôme Clerc, M. Groll, Damir J. Illich, Proceedings of the National Academy of Sciences Proteasome InhibitorsBioorganic ChemistryCritical DeterminantsChemical BiologyPharmaceutical Chemistry	2009	97
N-Acylation during Glidobactin Biosynthesis by the Tridomain Nonribosomal Peptide Synthetase Module GlbF H.J. Imker, Daniel Krahn, Jérôme Clerc, Chemistry & Biology BiosynthesisBiotransformationBiochemistryGlidobactin BiosynthesisNatural Product Biosynthesis	2010	86
Long-Term Radioiodine Retention and Regression of Liver Cancer after Sodium Iodide Symporter Gene Transfer in Wistar Rats J Faivre, Jérôme Clerc, René Gerolami, Cancer Research	2004	78
Proteasome Activity Imaging and Profiling Characterizes Bacterial Effector Syringolin A Izabella Kołodziejek, Johana C. Misas Villamil, Farnusch Kaschani, PLANT PHYSIOLOGY	2010	66
Syringolin A Selectively Labels the 20 S Proteasome in Murine EL4 and Wild‐Type and Bortezomib‐Adapted Leukaemic Cell Lines Jérôme Clerc, Bogdan I. Florea, Marianne Kraus, ChemBioChem	2009	63

Page 1